What is the Impact Factor of Journal of Skin Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Skin Cancer is 0.90, ranking in quartile Q4 of Web of Science (ESCI).

Is Journal of Skin Cancer indexed in Web of Science or Scopus?

Yes, Journal of Skin Cancer is indexed in Web of Science (ESCI, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.275 (Q3) and an H-index of 18.

Who publishes Journal of Skin Cancer and what is the Article Processing Charge (APC)?

Journal of Skin Cancer is published by Hindawi Limited. The estimated Article Processing Charge (APC) is approximately $2,726 USD, subject to institutional waivers and corresponding author affiliations.

WoS ESCI Q4Scopus Q3SCImago #18,133Gold OA

Journal of Skin Cancer

Identifier (ISSN):2090-2905(Print)/2090-2913(Online)

•

Publisher:Hindawi Limited

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

0.9↓ -1.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Journal of Skin Cancer

WoS Q4

Annual Impact Factor Metric

Current (2026):0.9

Scopus SJR & RankScopus Q3

0.275

#18,133

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

18 papers with at least that number of citations each

WoS: ESCIQ4

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

11articles/year

100% Gold OA•75% Original Research

Aims & Scope

Journal of Skin Cancer is a peer-reviewed, Open Access journal that publishes clinical and translational research on the detection, diagnosis, prevention, and treatment of skin malignancies. The journal encourages the submission of original research articles, review articles, and clinical studies related to pathology, prognostic indicators and biomarkers, novel therapies, as well as drug sensitivity and resistance.

Topics Covered (Recognized by AI)

Medicine99%Biology93.6%Internal medicine90.1%Genetics86.2%Pathology73.9%Cancer56.7%Dermatology47.3%Cancer research42.4%Surgery41.9%Chemistry34.5%Melanoma32%Immunology30.5%Basal cell30.5%Skin cancer29.1%Biochemistry27.6%Mathematics27.6%Radiology26.1%Psychology24.6%Sociology23.2%Basal cell carcinoma22.7%

Primary Research Areas

Dermatology

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

DERMATOLOGY

Rank82/99

IndexESCI

JCIESCI2026

DERMATOLOGY

Rank67/99

IndexESCI

Category	Index	Rank	Quartile
DERMATOLOGY	JCRESCI	82/99	Q4
DERMATOLOGY	JCIESCI	67/99	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF0.9

Articles / Year5

Total Citations0

2025

IF2

Articles / Year15

Total Citations12

2024

IF1.2

Articles / Year7

Total Citations21

2023

IF1.1

Articles / Year2

Total Citations4

2022

IF—

Articles / Year13

Total Citations240

Year	Impact Factor	Articles / Year	Total Citations
2026	0.9	5	0
2025	2	15	12
2024	1.2	7	21
2023	1.1	2	4
2022	—	13	240
2021	—	12	100
2020	—	8	80
2019	—	7	71
2018	—	5	97
2017	—	7	150
2016	—	9	128
2015	—	8	201

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #18,133Scopus Q3SCImago Profile

Scopus Coverage:2011-2012, 2014-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q3

0.275

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.25

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,726 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations41

3-Year Documents20

Citable Documents20

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate56.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

DermatologyQ3

OncologyQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

3区DERMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Skin Cancer (ISSN: 2090-2905) is a peer-reviewed international scholarly journal in the field of DERMATOLOGY, published by Hindawi Limited in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 0.90, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.275 (Q3), an H-index of 18.

The journal enforces rigorous peer evaluation with an annual output of approximately 11 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $2,726 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.